RAPP Rapport Therapeutics, Inc.

NEUTRAL Impact: 3/10 144
Horizon days Filed May 8, 2026 Processed 1mo ago SEC 0001974078-26-000173
Form 144 — notice of proposed sale of securities
Latest settled — T+5d
RAPP ▼ -8.46% at T+5d
NEUTRAL call ✗ call lost -8.46% · α vs SPY -8.37% · entry $38.43 → $35.18
Next anchor: T+20d due 5d ago
Currently $38.40 · -0.08% from $38.43 entry
Entry anchored
May 8, 2026
via day open
T+1d
-3.10%
call -3.10% · α -2.96%
$37.24
settled 5w ago
T+5d
-8.46%
call -8.46% · α -8.37%
$35.18
settled 29d ago
T+20d
call — · α —
due 5d ago
T+60d
call — · α —
in 7w

Price Chart

Loading chart...

Executive Summary

Third Rock Ventures V, L.P., a 10% stockholder, filed Form 144 to sell 5,018 shares of Rapport Therapeutics (RAPP) worth approximately $202,000. This is a minor sell-down following substantial recent sales by the same VC; the proposed amount represents less than 0.01% of market cap.

Actionable Insight

Monitor for further Form 144 filings from Third Rock Ventures; continued selling at this pace could signal reduced long-term conviction, but the current amount is negligible.

Key Facts

  • Third Rock Ventures V, L.P. filed Form 144 on 2026-05-08 for 5,018 shares of common stock.
  • Estimated aggregate value of proposed sale: $202,254.50.
  • Selling entity is a 10% stockholder (venture capital firm), not an executive.
  • Third Rock Ventures sold 426,005 shares on 04/17/2026 and 271,495 shares on 05/07/2026 in the prior three months.
  • RAPP market cap: ~$1.9B with ~47.8M shares outstanding; proposed sale is ~0.01% of market cap.

Financial Impact

~$202,000 (0.01% of market cap)

dilution

Risk Factors

  • Potential continued insider selling pressure if VC reduces position further.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
94% bullish (17 analysts)

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001974078-26-000173
Document: 0001974078-26-000173-index.html0001974078-26-000173
Document: 0001974078-26-000173.txt0001974078-26-000173
11 reports for RAPP
Performance horizon
75% Hit rate 3 of 4 directional calls best @ T+60▲ +24.87%Mar 10, 2026
Filters
Rows
Reports for RAPP — sortable, filterable
Type Now
Jun 11, 2026
2d ago
Institutional Cluster
NEUTRAL ★ 3/10
$35.19 awaiting T+5awaiting T+5$38.40 (+9.12%)
May 27, 2026
16d ago
144
BEARISH ★ 5/10
$39.51 $34.90▲ +11.67%▲ +12.88%$38.40 (+2.81%)
May 11, 2026
4w ago
144
BEARISH ★ 5/10
$37.24 $35.18▲ +5.53%▲ +5.61%$38.40 (−3.11%)
May 8, 2026
5w ago
144
NEUTRAL ★ 3/10
$38.43 $35.18▼ −8.46%▼ −8.37%$38.40 (−0.08%)
May 7, 2026
5w ago
144
NEUTRAL ★ 3/10
$38.04 $37.95▼ −0.24%▼ −1.70%$38.40 (+0.95%)
May 7, 2026
5w ago
8-K
MIXED ★ 6/10
$39.93 $38.08▼ −4.63%▼ −6.14%$38.40 (−3.83%)
Apr 23, 2026
7w ago
DEFA14A
NEUTRAL ★ 2/10
$36.36 $33.00▼ −9.24%▼ −10.72%$38.40 (+5.61%)
Apr 21, 2026
7w ago
Press Release
BULLISH ★ 8/10
$36.78 $33.30▼ −9.48%▼ −9.53%$38.40 (+4.40%)
Apr 1, 2026
10w ago
Press Release
NEUTRAL ★ 3/10
$31.67 $34.22▲ +8.05%▲ +4.29%$38.40 (+21.25%)
Mar 30, 2026
10w ago
144
NEUTRAL ★ 3/10
$31.29 $33.69▲ +7.67%▲ +3.73%$38.40 (+22.72%)
Showing 10 of 11

US Market Status

Market Closed — Opens Mon (48h 51m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access